D-0507-2025 Class II Ongoing
FDA drug recall D-0507-2025 was initiated by The Harvard Drug Group LLC on Jun 19, 2025 and is designated Class II. Reason for recall: Defective container; blister packaging inadequately sealed. The recall status is ongoing. Affected quantity: 23,232 cartons.
Recall details
- Product Type
- Drugs
- Report Date
- Jul 9, 2025
- Initiation Date
- Jun 19, 2025
- Voluntary/Mandated
- Voluntary: Firm initiated
- Product Quantity
- 23,232 cartons
Product description
Gabapentin Capsules, USP, 100 mg, 100 capsules (10x10), blister pack cartons, Rx only, Packaged and Distributed by: MAJOR PHARMACEUTICALS, Indianapolis, IN, 46268 USA, NDC 0904-6665-61
Reason for recall
Defective container; blister packaging inadequately sealed.
Distribution pattern
Nationwide
Code information
Lot# M05205, Exp Date 10/2026
Source
- Dataset
- openFDA drug recall enforcement reports
- FDA record
- This recall in openFDA (JSON)
- Enforcement Report
- Search FDA's Enforcement Report for D-0507-2025
- openFDA file date
- Nov 10, 2026
- Loaded by RegDataLab
- Nov 11, 2026